Abilify Asimtufii
NDC 59148-114, Aripiprazole, injection, suspension, extended release, from Otsuka America Pharmaceutical, Inc.
- Product NDC
- 59148-114
- Status
- Listed
- Labeler
- Otsuka America Pharmaceutical, Inc
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59148-114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ARIPIPRAZOLE960 mg/3.2mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59148-114-80 | 59148011480 | 1 SYRINGE in 1 CARTON (59148-114-80) / 3.2 mL in 1 SYRINGE |
| 59148-114-92 | 59148011492 | 1 SYRINGE in 1 CARTON (59148-114-92) / 3.2 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/da4c07fd-1130-4341-bb44-63acfa4162beMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=59148-114NADAC price for package 59148011480
GET /v1/drugs/nadac/59148011480
Use it
Look up 59148-114 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59148-114 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59148-114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.